Table 6.
Selected clinical trials using heat shock proteins (HSP).
| Reference | Patients | Immunologic response | Clinical response |
|---|---|---|---|
| [177] |
n = 12 recurrent GBM |
— | Median survival: 10.5 mo |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.